Results 101 to 110 of about 97,120 (173)

Patentes, regulación de precios e innovación en la industria farmacéutica [PDF]

The trade-off between property rights/price regulation and innovation depends on country characteristics and drug industry specificities. Access to drugs and innovation can be reconciled by seven ways that, among others, include: public health ...
Vicente Ortún
core  

[Controversies surrounding lung cancer screening]. [PDF]

Aten Primaria
Moreno-Bartolomé C, Navarro Soriano J, Melus Palazon E.   +2 more
europepmc   +1 more source

[Home-based care without longitudinality?] [PDF]

Aten Primaria, 2023
Riera Armengol L.
europepmc   +1 more source

[Gait Training Using Robotic Devices in Subjects With Stroke: An Overview of Systematic Reviews and Meta-analysis]. [PDF]

Rev Neurol
Chamorro-Hinojosa JA, Molina-Rueda F, Carratalá-Tejada M.   +2 more
europepmc   +1 more source

[Vaccination against the herpes zoster virus]. [PDF]

Aten Primaria, 2023
Gómez Marco JJ, Martín Martín S, Aldaz Herce P, Javierre Miranda AP, Sánchez Hernández C.   +4 more
europepmc   +1 more source

Drug innovation, prices and health [PDF]

This article tries to reconcile economic-industrial policy with health policy when dealing with biomedical innovation and welfare state sustainability. Better health accounts for an increasingly large proportion of welfare improvements.
Jaume Puig, María Callejón, Vicente Ortún   +2 more
core  

ESTUDIO DE LOS COSTES DIRECTOS SANITARIOS DE LOS PACIENTES CON DIABETES MELLITUS EN ESPAÑA [PDF]

Objetivo. Estimar el consumo de recursos sanitarios empleados en prevención y el tratamiento de pacientes con Diabetes Mellitus (DM) en España en el año 2002. Métodos. Estudio de coste de la enfermedad.
Begoña Molina, Félix Lobo, Juan Oliva, Susana Monereo   +3 more
core  

Evaluación del diseño y costo-efectividad de un modelo de pruebas en el lugar de atención para mejorar la capacidad de resolución de las urgencias hospitalarias. [PDF]

Adv Lab Med
Jimenez-Barragan M, Leon-Justel A, Sanchez-Mora C.   +2 more
europepmc   +1 more source

[Efficacy, effectiveness and safety of the adjuvanted influenza vaccine in the population aged 65 or over]. [PDF]

Rev Esp Quimioter, 2023
Arrazola Martínez MP, Eiros Bouza JM, Plans Rubió P, Puig-Barberà J, Ruiz Aragón J, Torres Lana AJ.   +5 more
europepmc   +1 more source

[Nirsevimab immunization effectiveness against respiratory syncytial virus hospitalization in newborns: two season of use in Navarre, Spain]. [PDF]

An Sist Sanit Navar
Vera-Punzano N, Navascués A, Armendáriz L, Viguria N, Herranz-Aguirre M, García Cenoz M, Trobajo-Sanmartín C, Echeverria A, Martínez-Baz I, Ezpeleta C, Ezpeleta G, Castilla J.   +11 more
europepmc   +1 more source